Clinical Core (Core B) is crucial to this Udall Center. It serves as a major resource for Projects 1 and 3, and Cores C and D. It will facilitate and expedite the translation of scientific discoveries (Project 3) to the clinical arena thanks to its large collection of families (more than 850 kindreds are followed by Core B) with Parkinson disease (PD)/Parkinsonism assembled by Core 8 during the past 26 years (last 13 years under the Udall Center program). Core B will share resources and collaborate with other Udall Centers (Johns Hopkins University, University of Washington, University of Pennsylvania, University of California Los Angeles, Feinstein Institute for Medical Research North Shore-Long Island Jewish Health System, and The University of Miami). Core B will collaborate with Core A, including educational and outreach platforms, and with nearby Florida institutions, the University of Florida Shands Jacksonville and the University of Florida in Gainesville. Core B has a well established track record of supporting the NINDS initiatives such as Coriell Repository, PD-DOC, collaborative GWAS studies or iPS research, and utilizing the common date elements (CDE). Core B has long included minorities in its studies and plans to further expand this work. It will continue to expand already longitudinally followed families with PD/Parkinsonism, with autopsy proven a- synuclein and tau accumulation (Aims 1 and 2), and with both known and unknown genetic status (Aim 3). It will expand kindreds by initiating pedigree construction/genealogical work starting with autopsied index cases (novel and complex approach). It will collect CDE data from familial and sporadic cases, controls, and new families for studies conducted in Project 1, other Udall Centers, and by qualified institutions outside the Udall Centers network (Aim 3). Core B will closely work with Core C and Project 1 on research leading to new gene discoveries. Core B will collect blood and skin biopsy specimens for Projects 1 and 3. Core B is responsible for obtaining appropriate Mayo IRB Committee approvals and reporting. It communicates with research subjects after a gene discovery has been made. Core B assists Core D in obtaining autopsies (Aim 4). Core B will also support educational and outreach activities of Core A.

Public Health Relevance

Clinical Core (Core B) functions include recruitment of patients, families, and controls for clinical, genetic, and pathological studies of Parkinson disease (PD)/Parkinsonism. It has been very successful in identification of large families and thus assisting in major genetic discoveries of Mayo Udall Center grant. Core B will serve as a large clinical resource center. It hopes to further enhance knowledge of clinical and molecular genetics that will undoubtedly lead to discovery of curative therapies for PD/Parkinsonism.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Specialized Center (P50)
Project #
5P50NS072187-04
Application #
8550147
Study Section
Special Emphasis Panel (ZNS1-SRB-J)
Project Start
Project End
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
4
Fiscal Year
2013
Total Cost
$302,601
Indirect Cost
$109,252
Name
Mayo Clinic Jacksonville
Department
Type
DUNS #
153223151
City
Jacksonville
State
FL
Country
United States
Zip Code
32224
Lorenzo-Betancor, Oswaldo; Wszolek, Zbigniew K; Ross, Owen A (2016) Rare variants in MC1R/TUBB3 exon 1 are not associated with Parkinson's disease. Ann Neurol 79:331
Kovacs, Gabor G; Ferrer, Isidro; Grinberg, Lea T et al. (2016) Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy. Acta Neuropathol 131:87-102
Tacik, Pawel; Sanchez-Contreras, Monica; Rademakers, Rosa et al. (2016) Genetic Disorders with Tau Pathology: A Review of the Literature and Report of Two Patients with Tauopathy and Positive Family Histories. Neurodegener Dis 16:12-21
Tipton, Philip W; Konno, Takuya; Broderick, Daniel F et al. (2016) Cerebral peduncle angle: Unreliable in differentiating progressive supranuclear palsy from other neurodegenerative diseases. Parkinsonism Relat Disord 32:31-35
Williams, Kelly L; Topp, Simon; Yang, Shu et al. (2016) CCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia. Nat Commun 7:11253
Ogaki, Kotaro; Koga, Shunsuke; Aoki, Naoya et al. (2016) Adult-onset cerebello-brainstem dominant form of X-linked adrenoleukodystrophy presenting as multiple system atrophy: case report and literature review. Neuropathology 36:64-76
Tacik, Pawel; Curry, Sadie; Fujioka, Shinsuke et al. (2016) Cancer in Parkinson's disease. Parkinsonism Relat Disord 31:28-33
Jiang, Peizhou; Gan, Ming; Yen, Shu-Hui et al. (2016) Proaggregant nuclear factor(s) trigger rapid formation of α-synuclein aggregates in apoptotic neurons. Acta Neuropathol 132:77-91
Soto-Ortolaza, Alexandra I; Ross, Owen A (2016) Genetic susceptibility variants in parkinsonism. Parkinsonism Relat Disord 22 Suppl 1:S7-11
Walton, Ronald L; Soto-Ortolaza, Alexandra I; Murray, Melissa E et al. (2016) TREM2 p.R47H substitution is not associated with dementia with Lewy bodies. Neurol Genet 2:e85

Showing the most recent 10 out of 218 publications